Brands, agencies and patients recognize Rare Disease Day
Pharma companies, healthcare brands and patient advocates took to the internet to raise awareness during Rare Disease Day 2024.
Source: mmm-online.com
Shin Ashida News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Shin Ashida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Shin Ashida Today - Breaking & Trending Today
JCR Pharmaceuticals' Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders | Region
HYOGO, Japan--(BUSINESS WIRE)--Feb 14, 2024--
Source: eagletribune.com
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
JCR Pharmaceuticals Co., Ltd. announced today that it will present six presentations at the 20th Annual WORLDSymposium™ 2024, to be held February 4-9, 2024 in San Diego, Calif. These presentations...
Source: marketscreener.com
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
JCR Pharmaceuticals Co., Ltd. announced today that Takeda Pharmaceutical Co., Ltd. decided to discontinue their collaboration with JCR to develop gene therapies using adeno-associated viruses ...
Source: marketscreener.com
U.S. FDA Grants Orphan Drug Designation to JR-441 for the Treatment of Mucopolysaccharidosis Type IIIA (MPS IIIA)
JCR Pharmaceuticals Co., Ltd. announced that the U.S. Food and Drug Administration granted orphan drug designation to JR-441, an investigational drug for the treatment of mucopolysaccharidosis...
Source: marketscreener.com